Status:
ACTIVE_NOT_RECRUITING
Clinical Evaluation of an Experimental Remineralization Product
Lead Sponsor:
Ivoclar Vivadent AG
Collaborating Sponsors:
Iuliu Hatieganu University of Medicine and Pharmacy
Conditions:
White Spot Lesion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is designed as a split-mouth randomised controlled study. This means within the mouth of one patient one tooth with an initial lesion is treated and coated with the Experimental Remineraliza...
Eligibility Criteria
Inclusion
- At least two incipient carious lesions on the buccal or oral surface of a permanent tooth. Neighbouring teeth should not be in two different groups. There is no maximum amount of lesions.
- Active caries lesion
- Patient at risk of caries
- Vital teeth
Exclusion
- Pregnancy
- Enamel detachment at the site of investigation
- Allergies (DoReMin)
- Chronic diseases
Key Trial Info
Start Date :
March 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06166849
Start Date
March 28 2023
End Date
April 30 2025
Last Update
April 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iuliu Hatieganu, University of Medicine and Pharmacy
Cluj-Napoca, Romania, 400012